Futureco Bioscience has announced that last week its BestCure biofungicide was awarded organic certification by the Organic Materials Review Institute (OMRI), one of the most prestigious and important organic certifications globally. The biofungicide allows farmers to improve the cultivation process, as well as obtain better yields, high quality fruits and reduce the application of chemical pesticides to meet the needs of markets that demand agrochemical-free products.
Futureco Bioscience obtained OMRI certification following Bestcure’s independent review of the organic standards in the biopesticide category of the National Organic Program (NOP). The approval procedure requires review of the product composition against the list of authorized ingredients and compliance with the manufacturing process standards required in organic production. With all the documentation submitted, OMRI determined that BestCure can be used in organic production in accordance with USDA National Organic Program regulations. Bestcure can now be marketed with the legend “OMRI listed for organic use”.
A report from Absolute Market Insights was recently released and discusses a comprehensive report on the global Biostimulants market, examining various patterns and factors influencing its progress. It provides in-depth data on market development, forecasts, and the impact of government policies. The report also analyzes the competitive landscape and profiles key players in the Biostimulants market. It covers business drivers, market trends, and industry forecasts, along with an assessment of innovations, advancements, and a value chain analysis. The report highlights the importance of market segmentation and offers insights into growth opportunities and strategies. It also includes a SWOT analysis and outlines major market segments based on active ingredients, mode of application, formulation, and crop type. Key players in the market include ADAMA, BASF SE, Koppert, UPL, and others.
Jaclyn (Krymowski) De Candio